Created at the initiative of the European Commission, member states and national organizations, EUP OHAMR aims to tackle the growing threat of antimicrobial resistance (AMR). This partnership adopts the "One Health" approach, which integrates the fields of human, animal and environmental health, recognizing the interdependence between these sectors.
EUP OHAMR brings together 53 organizations from 30 countries, including government agencies, research institutions and funding bodies. The partnership will last ten years (2025-2035).
EUP OHAMR aims to:
- strengthen research and innovation based on the integrated "One Health" approach;
- developing innovative solutions to contain antimicrobial resistance;
- aligning policies, funding and actors to ensure coherence in action;
- promoting the translation of scientific knowledge into practice;
- build capacity and share infrastructures, strengthening the European AMR research network.
This partnership is in line with the European plan European One Health Action Plan against AMR and with Global Health Strategy for 2025-2028of the World Health Organization.
FCT and the Agency for Clinical Research and Biomedical Innovation are the Portuguese organizations that are part of OHAMR.
This initiative has received funding from the European Union's Horizon Europe research and innovation program. Grant agreement n° 101217154.
